Acute myeloid leukemia in the elderly: do we know who should be treated and how?
about
The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabineA phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia.Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.AML therapy in the elderly: a time for a change.The changing face of acute myeloid leukemia therapeutics in the elderly population.Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia.Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?Clinical decision making in cancer care: a review of current and future roles of patient age.
P2860
Q34979606-A6FD6C28-9ACE-497E-8E9B-5AF2016DE77FQ36682845-ED9EAD84-2F60-45E4-B23F-511FB0916F85Q37221579-33DDD79B-1D50-4E8B-9C9F-E535C29AD764Q37278653-C9C118E4-F1D3-49C9-BB9F-F67033FE75D2Q37310474-5A491D3E-8C39-476A-8753-3BEA4D5FC5AAQ38850054-84F4E377-D198-4FE5-8A61-CDCEB1DD896BQ39311595-542ECC01-0548-44F8-A22F-F020F51576E7Q40376093-A6212B05-180C-4E28-AE67-665DC9BECECBQ40813160-FB1D6EDA-5928-46AE-A889-EFAD27140192Q41763410-580F3F18-7907-427E-928F-506940600134Q50234387-68D270C1-6E96-4C97-B86F-131C42C886C7Q53804314-E11F2E4B-1C3C-4604-B8DB-6270D5412FF0Q55135907-2028587F-EE2C-4572-882C-757F6824EE37
P2860
Acute myeloid leukemia in the elderly: do we know who should be treated and how?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Acute myeloid leukemia in the elderly: do we know who should be treated and how?
@en
type
label
Acute myeloid leukemia in the elderly: do we know who should be treated and how?
@en
prefLabel
Acute myeloid leukemia in the elderly: do we know who should be treated and how?
@en
P2860
P1433
P1476
Acute myeloid leukemia in the elderly: do we know who should be treated and how?
@en
P2093
Aziz Nazha
P2860
P304
P356
10.3109/10428194.2013.828348
P577
2013-08-28T00:00:00Z